Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society - 1 Jul 2014

Sarles Jacques, Giorgi Roch, Berthézène Patrice, Munck Anne, Cheillan David, Dagorn Jean-Charles, Roussey Michel

Abstract excerpt

BACKGROUND: French health authorities promoted a study on 553,167 newborns comparing the performances of IRT/DNA and IRT/PAP for CF newborn screening. METHODS: In parallel to IRT/DNA, PAP was assayed in newborns with IRT>50 μg/L. Provisional PAP cutoffs at 3.0 μg/L when 50<IRT<100 μg/L and 1.7 μg...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Trypsinogen
Share to Antigens, Neoplasm
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Follow-Up Studies

Share to Lectins, C-Type

Share to Neonatal Screening

Share to Pancreatitis-Associated Proteins

Source

Identifiers

PMID: 24513262
DOI: 10.1016/j.jcf.2014.01.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24513262-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP.PMID 24513262Read ↗

[Newborn screening for cystic fibrosis in France].Semantic proximity Read ↗

Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy.Semantic proximity Read ↗

Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.Semantic proximity Read ↗

Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study.Semantic proximity Read ↗

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.Semantic proximity Read ↗

False-positive results in neonatal screening for cystic fibrosis based on a three-stage protocol (IRT/DNA/IRT): Should we adjust IRT cut-off to ethnic origin?Semantic proximity Read ↗

Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic StudiesSemantic proximity Read ↗

Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.Semantic proximity Read ↗

Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process.Semantic proximity Read ↗

Four-year evaluation of neonatal cystic fibrosis screening in Southern Belgium.Semantic proximity Read ↗

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.Semantic proximity Read ↗

Cystic fibrosis newborn screening in a high prevalence population - Ten years' experience in Ireland.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.